Recombinant human brain natriuretic peptide (rhBNP) ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
215Tetralogy of Fallot1

215. Tetralogy of Fallot


Clinical trials : 22 Drugs : 48 - (DrugBank : 19) / Drug target genes : 18 - Drug target pathways : 49
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01941576
(ClinicalTrials.gov)
September 1, 20133/9/2013Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of FallotEffects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of FallotCongenital Heart Defects;Tetralogy Of FallotDrug: recombinant human brain natriuretic peptide (rhBNP);Drug: Placebo (0.9% sodium chloride)Shanghai Jiao Tong University School of MedicineNULLCompleted1 Month18 YearsAll120N/AChina